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ABSTRACT
Background. The outcomes of paraaortic lymphadenec-
tomy were compared for the treatment of gynecological
malignancies to identify the most appropriate surgical
approach.
Methods. Our retrospective, multicentric study included
1304 patients who underwent paraaortic lymphadenectomy
for gynecological malignancies. The patients were cate-
gorized into the following five groups based on treatment
type: transperitoneal laparoscopy (group A, n = 198),
extraperitoneal laparoscopy (group B, n = 681), robot-as-
sisted transperitoneal laparoscopy (group C, n = 135),
robot-assisted extraperitoneal laparoscopy (group D,
n = 44), and laparotomy (group E, n = 246).
Results. The prevalence of cancer types differed accord-
ing to the surgical approach: there were more ovarian
cancers in group E and more cervical cancers in groups B
and D (p\ 0.001). Estimated blood loss was higher in
group E (844.2 mL) than in groups treated with minimally
invasive interventions (115.8–141.5 mL, p\ 0.005). For
infrarenal dissection, fewer nodes were removed in group
C compared with the other approaches (16 vs. 21 nodes,
respectively, p\ 0.05). The average operative time ranged
from 169 min for group A to 247 min for group E
(p\ 0.001). Length of hospital stay was 14 days for group
E versus 3.5 days for minimally invasive procedures
(p\ 0.05). The early postoperative grade 3 and superior
Dindo–Clavien complications occurred in 9–10% of the
patients in groups B-D, 15% of the patients in group E, and
only 3% and 4% for groups A and C, respectively. The
most common complication was lymphocele.
Conclusions. Laparotomy increases preoperative and
postoperative morbidity. The robot-assisted transperitoneal
approach demonstrated a poorer lymph node yield than
laparotomy and extraperitoneal approaches.
Paraaortic lymphadenectomy (PAL) is a routine proce-
dure for staging or therapeutic purposes of gynecological
malignancies. The purpose of conventional interventions in
cervical cancers and advanced vaginal cancers is to guide
the fields of radiation and for therapeutic benefits.1,2 In
endometrial cancer, PAL is therapeutic; however in high-
risk endometrial cancers, PAL also acts to guide the irra-
diation.3 In adnexal cancers, PAL is performed for
therapeutic purposes, although recent data may call into
question some of its interests.
Historically, PAL was systematically performed by
laparotomy, and this is still the first route of choice,
especially in ovarian cancers. Nevertheless, for several
decades, transperitoneal and retroperitoneal laparoscopy
also have been used to perform this procedure. More
recently, robot-assisted PAL has been introduced. The
development of minimally invasive surgery, particularly
with respect to lymphadenectomy, meets the need to
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perform adjuvant treatments as soon as possible after sur-
gery. In this context, the interest of laparoscopy
(transperitoneal or extraperitoneal) is demonstrated.4–6
Studies show that lymphadenectomy procedures by
robot-assisted laparoscopy have good feasibility but are not
superior to the laparoscopic approach alone. Each of these
approaches has its own advantages and limitations, and the
utility of each procedure is dependent on the type of can-
cer, the stage of the disease and the patient concerned.
Thus, our objective is to evaluate the outcomes of PAL for
the treatment of gynecological malignancies according to
the surgical approach.
METHODS
This retrospective study involved multiple centers
across France and Belgium. The six participating cancer
surgery centers were: The Oscar Lambret Center, Lille;
University Hospital of Liège, Liège; Institut Paoli-Cal-
mettes, Marseille; Hospital Européen Georges Pompidou,
Paris; University Hospital of Tours; and Citadelle Hospital,
Liège. All centers were included for their specificities
regarding type of surgical procedures.
This study included patients who had PAL for the
treatment of gynecological cancer between 2006 and 2015.
The PAL was performed in each center according to five
different modalities: transperitoneal laparoscopy,
extraperitoneal laparoscopy, robot-assisted transperitoneal
laparoscopy, robot-assisted extraperitoneal laparoscopy,
and laparotomy. Robotic procedures were performed after
2010. The extraperitoneal approach was used at the
beginning of the data collection (2006). Patients who had
received debulking procedures (adenectomy) were exclu-
ded from the study. The clinical decision for PAL was
made for the treatment of one of the following gyneco-
logical conditions: cancer of the endometrium, ovary,
cervix, and vagina. The included patients presented cancers
of different stages and various pathological characteristics.
The clinical indications for PAL in cervical cancer were:
IB1 FIGO stage carcinoma in cases of pelvic lymph node
involvement, and cervical cancer of stage IB2 or higher.
For endometrial cancers, PAL was performed for the first
time in cases of high risk and high/intermediate risk. PAL
also was performed a second time when the severity of the
case was initially underestimated. PAL was performed for
the treatment of adnexal cancers with a higher stage than
FIGO IC.
The choice of surgical approach was decided in a mul-
tidisciplinary consultation meeting, in agreement with the
surgeon referring the patient. PAL was systematically
performed up to the level of the left renal vein (IR), except
in some patients with cervical cancer (since 2013), in
which case the upper limit was the inferior mesenteric
artery (IMA). The data collected were: body mass index
(BMI), age, surgical approach, dissection level, number of
lymph nodes, marsupialization, blood loss, skin-to-skin
operative time, peri- and postoperative complications, and
length of stay in the hospital. The classification of Dindo–
Clavien7 for postoperative complications was used: grades
I and II were considered minor, whereas grades III or
higher were major. All surgeries were performed by sur-
geons with experience in minimally invasive surgery and
robot-assisted laparoscopy. In some patients, other proce-
dures were performed concomitantly, such as hysterectomy
with bilateral salpingo-oophorectomy, omentectomy,
appendicectomy, and pelvic lymphadenectomy. The char-
acteristics of the patients are presented using the standard
methods of descriptive statistics: frequencies and percent-
age for categorical variables; medians, extreme values,
means and standard deviations for continuous variables.
The difference between the proportions of the first path-
ways (such as age, BMI, and blood loss, depending on the
pathway) is analyzed using the Chi square test or the Fisher
exact test (if the theoretical size is less than 5). For the
prognostic factor analysis, logistic regression analysis is
used. The software used for statistical analysis was Stata
v13.1 (StataCorp, 2013. Stata Statistical Software: Release
13. College Station, TX: StataCorp LP).
RESULTS
Our retrospective, multicenter study included 1304
patients who received PAL for gynecological cancers. The
patients were divided into the following five groups,
depending on their treatment type: transperitoneal laparo-
scopy (group A, n = 198), extraperitoneal laparoscopy
(group B, n = 681), transperitoneal robotic laparoscopy
(group C, n = 135), robot-assisted extraperitoneal laparo-
scopy (group D, n = 44) and laparotomy (group E,
n = 246). Table 1 describe the distribution of procedure in
the different centers. The distribution of type of cancer
differed according to the surgical approach; there were
more ovarian cancers in group E and more cervical cancers
in groups B and D, p\ 0.001. Only 15% of our patients,
especially those operated on after 2013, received an
inframesenteric artery dissection. Most patients received a
complete infra-renal dissection. The transperitoneal robotic
laparoscopy was mainly performed in two centers and
using simple docking technique. No differences were found
in BMI between groups, but the proportion of patients with
BMI C 30 kg/m2 was significantly higher in extraperi-
toneal groups (Table 2). No differences were observed in
age between groups, but there were significantly more
patients younger than age 60 years in the minimally
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invasive groups. The mean estimated blood loss was higher
in group E (844.2 mL) compared with the minimally
invasive groups (115.8–141.5 mL, p\ 0.005). The mean
operative time ranged from 169 min in group A to 247 min
in group E (p\ 0.001). The operative time was signifi-
cantly lower in extraperitoneal groups. The duration of stay
was 14 days for group E versus 3.5 days for minimally
invasive procedures (p\ 0.05; Table 3). During infrarenal
dissection, fewer lymph nodes were removed in group C
compared with the other groups (16 vs. 21 nodes, respec-
tively, p\ 0.05).
Complications with postoperative grade 3 and higher
(classified using the Clavien–Dindo system) occurred in
9–10% and 15% of patients in groups B-D and group E,
respectively, and in only 3% and 4% of groups A and C,
respectively. Acute morbidity (grades 1–3 of the Clavien–
Dindo classification) was more common in extraperitoneal
groups and laparotomy than for transperitoneal groups. On
the other hand, severe morbidity (grades 4–5) is higher for
the laparotomy group than for the minimally invasive
groups (Table 4). The most common complication was
lymphocele. A univariate logistic regression analysis




















Centers N % N % N % N % N % N %
Citadelle Hospital, Liège 0 0.00 0 0.00 38 28.10 0 0.00 14 5.70 52 4.00
University Hospital of Tours 0 0.00 47 6.90 4 3.00 0 0.00 0 0.00 51 4.00
University Hospital of Liège 76 38.40 13 1.90 0 0.00 0 0.00 0 0.00 89 6.80
Oscar Lambret Center, Lille 122 61.60 571 83.80 11 8.10 32 72.70 232 94.30 967 74.15
Hopital Européen Georges Pompidou,
Paris
0 0.00 50 7.30 0 0.00 12 27.30 0 0.00 62 4.70
Institut Paoli-Calmettes, Marseille 0 0.00 0 0.00 82 60.70 0 0.00 0 0.00 82 6.30
Total 198 681 135 44 246 1304














n (%) n (%) n (%) n (%) n (%)
Age (year)
\ 60 145 (74.7) 527 (79) 87 (66.4) 31 (70) 112 (46.1) \ 0.002
C 60 49 (25.3) 140 (20) 44 (33.6) 13 (30) 131 (53.9)
BMI (kg/m2)
\ 30 161 (88) 491 (80.5) 115 (90.6) 31 (70) 154 (71.3) \ 0.02
C30 22 (12) 119 (19.5) 12 (9.4) 13 (30) 62 (28.7)
Localization
Cervix 104 (56.5) 572 (85.5) 78 (59.5) 37 (84) 0 (0) \ 0.001
Endometrium 41 (22.3) 41 (6.1) 35 (26.7) 7 (16) 80 (32.5)
Ovary 39 (21.2) 54 (8.1) 18 (13.7) 0 (0) 166 (67.5)
Vagina 0 (0) 2 (0.1) 0 (0) 0 (0) 0 (0)
Level of dissection
IMA 82 (42.3) 79 (11.8) 41 (40.2) 6 (13.6) 0 (0)
IR 112 (57.7) 592 (88.2) 61 (59.8) 38 (86.4) 233 (100)
BMI body mass index, IMA inframesenteric artery, IR infrarenal
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allowed us to identify the following as prognostic factors:
the appearance of symptomatic lymphoceles; obesity
(BMI[ 30); age younger than 60 years; the number of
lymph nodes removed; and the use of the extraperitoneal
approach. Marsupialization reduced the number of lym-
phoceles in the extraperitoneal groups (Table 5).
DISCUSSION
The number of lymph nodes removed showed no sig-
nificant differences between groups, with the exception of
the transperitoneal robot-assisted laparoscopy group. These
results are in agreement with the literature.8 Parkish et al.
compared the transperitoneal and extraperitoneal approa-
ches performed by laparoscopy and robot-assisted
laparoscopy for the treatment of endometrial cancer. The


















Operative time (n = 653) 103 381 60 43 66
Mean 214.6a,b 207.1c,d 257.1 220.2e 250.5
SD 88.3 73.4 117.1 63.9 70.1
Blood loss (n = 223) 0 74f,g 92h 31i 26
Mean NA 116.9 141.5 115.8 844.2
SD NA 407.9 265.7 134.5 965.1
Hospital stay (n = 700) 178 338 77 43 64 0.0001
Median 3j 3 k 3 3 9
Range 1–24 1–41 1–19 1–16 4–84
Lymph nodes (n = 1207) 180 645 108 41 233 \ 0.02
Median 14 18 13 20 19
Range 1–51 1–53 0–49 3–50 1–84
aGroup 1 compared with group 2, p = 0.04
bGroup 1 compared with group 5, p = 0.002
cGroup 2 compared with group 3, p = 0.004
dGroup 2 compared with group 5, p = 0.0001
eGroup 4 compared with group 5, p = 0.005
fGroup 2 compared with group 3, p = 0.0004
gGroup 2 compared with group 5, p = 0.0001
hGroup 3 compared with group 5, p = 0.0001
iGroup 4 compared with group 5, p = 0.0001
jGroup 1 compared with group 2, p = 0.0001
kGroup 2 compared with group 3, p = 0.0004

















8 (4) 8 (1.2) 1 (0.7) 1 (2.3) 9 (3.7)
Grade 3, n (%) 14 (7.1) 75 (11) 5 (3.7) 6 (13.6) 25 (10.2)
Grade 4, n (%) 1 (0.5) 1 (0.1) 0 (0) 0 (0) 1 (0.4)
Grade 5, n (%) 0 (0) 2 (0.3) 0 (0) 0 (0) 2 (0.8)
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number of lymph nodes removed was significantly lower in
the transperitoneal approach, regardless of BMI. Never-
theless, there was no significant difference between the
laparoscopic transperitoneal approach and the robot-as-
sisted laparoscopy, unlike the findings of our study.
The first explanation for this inconsistency between
studies is that, in a large number of robotic transperitoneal
procedures in our study, double docking was not achieved,
thus preventing a more extensive lymph node dissection.9
Lymph node dissection rate also could be influenced by the
fact that some of the robotic procedures were performed
with the older generation of the Da Vinci S robot (Intuitive
Inc, Sunnyvale, CA).10 Second, in our study, there were
more patients with BMI C 30 kg/m2 in the extraperitoneal
groups. With increased BMI, transperitoneal lym-
phadenectomy may not have been sufficient to adequately
collect the lymph nodes of the renal vessels because of
poor visualization, due to increased intraabdominal adipose
tissue. Ponce et al.11 suggested that a learning curve of 20
cases was necessary to manage properly the surgical
technique. In our study, mainly two centers performed this
procedure routinely. In the other centers, the learning curve
of 20 cases was not achieved. The extraperitoneal approach
provides an alternative means for complete lymphadenec-
tomy in this patient population. An ongoing, randomized
trial (STELLA Trial: Transperitoneal vs. Extraperitoneal
Approach for Laparoscopic Staging of Endometrial Cancer
and Ovarian Cancer [NCT01810874]) will clarify the
potential benefits of extraperitoneal PAL compared with
the transperitoneal approach.
The extraperitoneal approach was associated with sev-
eral advantages over the transperitoneal approach: namely
shorter operative time and shorter hospital stay. Therefore,
when possible, this approach may be the most appropriate
route of PAL. Nonetheless, an increased number of mild
complications was observed in the extraperitoneal groups.
Most of these complications were percutaneous drainages
for symptomatic lymphoceles (grade 3a). These findings
are in agreement with previous studies investigating the
role of extraperitoneal laparoscopic PAL in gynecologic
malignancies, which have shown that this procedure is both
safe and feasible.12–14
As mentioned above, the most common delayed com-
plication in our study was lymphocele. The prognostic
factors for the onset of symptomatic lymphocele were
obesity (BMI[ 30), age younger than 60 years, an
increased number of lymph nodes removed, and use of the
extraperitoneal approach. Regarding the extraperitoneal
approach, it became obvious that marsupialization was a
protective factor against lymphoceles. Thus,
TABLE 5 Predictive factors of
lymphocele
Factors Events/total OR (IC 95%) p
BMI
\ 30 52/618 1 0.004
C 30 25/153 2.17 (1.30–3.63)
Age (year)
\ 60 65/578 1 0.01
C 60 13/226 0.48 (0.26–0.89)
Upper limit of dissection
IR 88/1036 4.34 0.02
IMA 9/207 8.49
Number of lymph nodes harvested 1.03 (1.01–1.05) 0.08
Localization
Cervix 77/789 1 0.005
Endometrium 7/204 0.33 (0.15–0.72)
Ovary 10/266 0.36 (0.18–0.71)
Others 1/14 0.71 (0.09–5.51)
Surgical approach
Minimally invasive transperitoneal 5/144 1 \ 0.0001
Minimally invasive extraperitoneal 66/476 3.51 (1.38–8.92)
Laparotomy 9/233 0.88 (0.29–2.68)
Marsupialization
No 30/145 1 0.01
Yes 19/177 0.46 (0.25–0.86)
BMI body mass index, IMA inframesenteric artery, IR infrarenal
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marsupialization was initiated in patients who had been
operated on more recently. This helps to explain why so
few patients have benefited from the extraperitoneal
approach. Nevertheless, it is likely that the difference in
complications would have been more significant with a
greater number of study participants. Systematic marsupi-
alization at the end of the extraperitoneal procedure has not
yet been evaluated prospectively. Therefore, data in the
literature to corroborate or invalidate our result are limited,
except for one study published by our team.15
Only one published study compares the laparoscopic
robot-assisted approach to the laparoscopic approach.16
Dıaz-Feijoo et al. compared the results of 17 and 83
patients undergoing extraperitoneal lymphadenectomy by
robot-assisted laparoscopy and laparoscopic surgery,
respectively. The authors observed that the operative time,
the duration of hospitalization, and the rate complications
were similar between the two approaches. However, robot-
assisted laparoscopy was associated with decreased blood
loss [20 mL, (range, 5–350) vs. 90 mL (range, 10–260)]
and a greater number of lymph nodes [17 (range, 10–31)
vs. 14 (range, 4–62)] compared with conventional laparo-
scopy (p\ 0.05). The data from our study support these
findings, except for the findings regarding increased lymph
node dissection. This could be explained by a lack of
participants in the robotic group.
Our study was retrospective, which means that bias
could have affected the choice of the surgical approach.
Due to the modalities of date collection, there are numer-
ous missing information on perioperative data (Table 3)
that could possibly influence our results. Furthermore, it
was not possible to assess the patients’ quality of life, or
information on patients’ preferences for cosmetic results
after the various surgical approaches. Other weaknesses
include our inability to evaluate the data based on the
surgeon’s learning curve and the team’s experience. This
would be particularly interesting to assess how the growing
experience of robotic surgery influences docking and
operative time. Another limitation is the lack of standard-
ized follow-up in different studies. In fact, it is possible that
long-term events (late complications) occurred after pub-
lication. We did not perform a cost analysis between the
groups.
CONCLUSIONS
Mild morbidity is higher in the groups who underwent
laparotomy and extraperitoneal approaches. On the other
hand, serious morbidity is higher in the group who
underwent laparotomy. Marsupialization and IMA
dissection is an effective way to reduce the risk of post-
operative lymphocele. Randomized trials are required to
confirm the benefit of the extraperitoneal and robot-assisted
routes.
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